Download 8-25-2016 PPT

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Prescription costs wikipedia , lookup

Neuropharmacology wikipedia , lookup

Drug discovery wikipedia , lookup

Drug design wikipedia , lookup

Bad Pharma wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Drug interaction wikipedia , lookup

Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup

Bilastine wikipedia , lookup

Intravenous therapy wikipedia , lookup

Theralizumab wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Plateau principle wikipedia , lookup

Transcript
INTRAVASCULAR DOSING
PHARMACOKINETICS
ALLIE PUNKE
[email protected]
CONTINUOUS IV INFUSION
 Continuous IV infusion (CIVI) releases the drug at a
constant rate.
 In contrast to IV Bolus, where the maximum
concentration occurs ___________, the maximum
concentration for continuous IV infusion occurs
____________.
 Basic equation:


IV Bolus equation: Ct=
CIVI equation:
Continuous IV infusion
 A drug is being given by continuous IV infusion at a
rate of 10 µg/hour to reach the steady state
concentration of 46 mg/L. What should the infusion
rate be increased to in order to reach a steady state
concentration of 120 mg/L?
Ln concentration
Concentration Time Profiles
Infusion
is stopped
During
infusion, at
steady state
During
infusion, before
steady state
Post infusion
Time
 General Expression for plasma concentration:
Ct= R0 * (1-e-k * Tinf) (e-k * ( t - Tinf))
Only important before
Only important after
CL
steady state has been
achieved
the infusion is ended
Ln concentration
During infusion, before steady state
Infusion
is stopped
During
infusion, before
steady state
Reasoning:
Since time and time
of infusion are equal,
t = Tinf, this term
becomes e0 = 1.
Time
 General Expression for plasma concentration:
Ct= R0 * (1-e-k * Tinf) (e-k * ( t - Tinf))
CL
Only important before
steady state has been
achieved
Only important after
the infusion is ended
Ln concentration
During infusion, at steady state
Infusion
is stopped
During
infusion, at
steady state
Reasoning:
Since time and time of
infusion are equal, t = Tinf,
this term becomes e0 = 1.
When Tinf > Tss = 5*T1/2,
then we assume e→∞ = 0.
[1 ─ 0 = 1] making this
term 1.
Time
 General Expression for plasma concentration:
Ct= R0 * (1-e-k * Tinf) (e-k * ( t - Tinf))
CL
Only important before
steady state has been
achieved
Only important after
the infusion is ended
Ln concentration
After infusion, before steady state
Infusion
is stopped
Reasoning:
Both terms are
necessary for
finding Ct.
After infusion,
before steady
state
Time
 General Expression for plasma concentration:
Ct= R0 * (1-e-k * Tinf) (e-k * ( t - Tinf))
CL
Only important before
steady state has been
achieved
Only important after
the infusion is ended
After infusion that ended at steady state
Ln concentration
Infusion
is stopped
Post infusion,
after steady state
was reached
Reasoning:
When Tinf > Tss = 5*T1/2,
then we assume e→∞ = 0. [1
─ 0 = 1] making this term
1.
Time
 General Expression for plasma concentration:
Ct= R0 * (1-e-k * Tinf) (e-k * ( t - Tinf))
CL
Only important before
steady state has been
achieved
Only important after
the infusion is ended
Continuous IV infusion
 A patient is receiving a drug by CIVI at a rate of 800 mg/h to reach a
steady state concentration level of 60 mg/L. A blood level drawn at 7
hours results in a concentration of 40 mg/L.

What is the half-life?

What is the CL?

How long to reach steady state?
Continuous IV Infusion
 Maximum concentration after 40 hours?
 Suppose the team decides that a level of 47 mg/L is desired.
What should the new rate be?
Continuous IV Infusion
 A patient is started on a CIVI at a rate of 150 mg/h to reach
Css of 6 mg/L. A blood level of 4 mg/L is drawn at 16 hours.

What is the half-life of the drug?

What is the CL?

When is steady state reached?

What is the maximum concentration achieved if the infusion runs for 36
hours?
Loading Dose
 What LD would we give this pt initially to reach a Css
of 6mg/L?
 What LD would we give if the patient has a
concentration of 6 mg/L, and we want to achieve a
concentration of 14 mg/L?
Maintenance Dose
 What would the MD be to achieve 10 mg/L?
Loading and Maintenance Dosing
 If CL is increased, this affects:
 A. Loading dose
 B. Maintenance dose
 C. Both
 D. Neither loading or maintenance dose
CIVI is Stopped
 After CIVI is stopped, at hours 2 and 12, the
concentrations were 12.9 mg/L and 6 mg/L.

What is the concentration at the end of the infusion?

What will the concentration be 24 hours after the infusion was
stopped?
Short term infusion
 HP is given a 1000mg dose of vancomycin over a 30 min infusion.
Levels are taken at 1 hour and 3 hours and found to be 20mg/L and
14mg/L respectively. The population Vd for vancomycin is 44L.
 What is the concentration at 5 hours?
Short term infusion
 When will the concentration be below 7mg/L?
Cumulative Drug in Urine
 If Drug X has an fe=1 and a pt is given a dose of 2
grams IVB what will the ΣDu be at t=∞?
 What if fe=0.75?
Calculate kr
 Calculate kr using the following time points
(specifically using Time 4 and 6):
Time
Du (mg)
0
400
1
356
2
301
4
278
6
231
8
199
Du/t
Rate
t*
Calculate FE
 What is FE if kr is the value found in the previous
problem and you have the following information:

A patient is given 400 mg IVB. At 4 hours, the concentration
was 16 mg/L and at 10 hours, the concentration was 5 mg/L.
Extravascular Dosing
 You have to take into account bioavailability now!
 Calculate the bioavailability (F):
 72% is not absorbed, 23% does not get first-pass metabolized
by the liver, and 80% is metabolized by the gut
Extravascular Dosing
 A patient is taking a new drug (500 mg) that has the
population values of:


Half-life: 8 hours, Vd: 50 L, kr: 0.021 h-1, Ka: 1.45-1, 90%
reaches the bloodstream
Solve for:

K

FE

CL (total)
Extravascular Dosing (Continued)

CL (renal)

Cmax

Tmax

AUC
Extravascular Dosing
 What is it called when
the absorption phase is
the rate limiting step?
 If you were given time
points with
concentrations and told
to assume the drug
followed flip-flop
kinetics, how could you
calculate ka?
Summary
 Things to think about when making calculations for
the exam:


1. Is it IVB, CIVI, or oral medications?
2. If it is CIVI, has it been stopped or is it still running?
 Double check your work!
 Think about if your answers actually make sense based on the
information given.
 Good luck!